The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson’s disease mouse model
Saebom Lee(Johns Hopkins University), Han Seok Ko(Orthopaedic Research Foundation)
Cited by 83
Related Papers
Activation of tyrosine kinase c-Abl contributes to α-synuclein–induced neurodegeneration
|Journal of Clinical Investigation|2016|208
Depression research: where are we now?
|Molecular Brain|2010|167